Swiss Life Asset Management Ltd Boosts Stock Position in Kenvue Inc. $KVUE

Swiss Life Asset Management Ltd boosted its position in Kenvue Inc. (NYSE:KVUE) by 19.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 435,899 shares of the company’s stock after acquiring an additional 69,887 shares during the period. Swiss Life Asset Management Ltd’s holdings in Kenvue were worth $7,519,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Arrowstreet Capital Limited Partnership acquired a new position in shares of Kenvue during the second quarter worth $6,528,000. Jump Financial LLC raised its stake in Kenvue by 210.6% in the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after buying an additional 37,170 shares during the last quarter. AXA S.A. raised its stake in Kenvue by 21.1% in the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after buying an additional 8,524 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of Kenvue by 219.1% during the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock worth $2,040,000 after acquiring an additional 66,930 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Kenvue by 0.6% during the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after acquiring an additional 10,885 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently commented on KVUE shares. Citigroup decreased their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. UBS Group cut their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Argus upgraded shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Finally, Barclays dropped their price objective on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $19.33.

Insider Activity

In related news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.59% of the stock is currently owned by company insiders.

Kenvue Trading Down 1.5%

Kenvue stock opened at $17.22 on Thursday. The stock has a 50-day moving average price of $17.52 and a 200 day moving average price of $17.30. The company has a market capitalization of $33.05 billion, a price-to-earnings ratio of 20.25, a price-to-earnings-growth ratio of 1.33 and a beta of 0.55. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $24.35. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter in the prior year, the company earned $0.24 EPS. Kenvue’s quarterly revenue was up 4.5% on a year-over-year basis. Sell-side analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s dividend payout ratio is presently 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.